RNA Binding Fox-1 Homolog 2 (RBFOX2) is an alternative splicing regulator crucial for neuronal development and function. This page provides comprehensive information about its structure, molecular function, disease associations, and therapeutic relevance in neurodegeneration.
The gene symbol for this protein is RBFOX2, with the full name being RNA Binding Fox-1 Homolog 2 [@bhardwaj2024]. RBFOX2 is located at chromosomal position 22q12.3 [@zhang2020] and has been assigned the NCBI Gene ID 61643 [@vuong2023], OMIM identifier 607348 [@carpentier2022], UniProt accession Q9BQY4 [@liu2021], and Ensembl ID ENSG00000100320 [@sterneweiler2024]. This gene encodes a protein-coding product and is classified as a protein-coding gene type [@bhardwaj2024]. The gene is notably associated with several diseases including Amyotrophic Lateral Sclerosis (ALS), Parkinson's Disease, Cancer, Epilepsy, and Autism Spectrum Disorder [@bhattacharya2021].
RBFOX2 is located on chromosome 22q12.3 and encodes an RNA-binding protein. The gene contains multiple exons and undergoes extensive alternative splicing to produce various isoforms. The protein is characterized by an RNA recognition motif (RRM) domain that facilitates binding to specific RNA sequences.
RNA Binding Fox-1 Homolog 2 (RBFOX2) is an alternative splicing regulator crucial for neuronal development and function. This page provides comprehensive information about its structure, molecular function, disease associations, and therapeutic relevance in neurodegeneration.
The gene symbol for this protein is RBFOX2, with the full name being RNA Binding Fox-1 Homolog 2 [@bhardwaj2024]. RBFOX2 is located at chromosomal position 22q12.3 [@zhang2020] and has been assigned the NCBI Gene ID 61643 [@vuong2023], OMIM identifier 607348 [@carpentier2022], UniProt accession Q9BQY4 [@liu2021], and Ensembl ID ENSG00000100320 [@sterneweiler2024]. This gene encodes a protein-coding product and is classified as a protein-coding gene type [@bhardwaj2024]. The gene is notably associated with several diseases including Amyotrophic Lateral Sclerosis (ALS), Parkinson's Disease, Cancer, Epilepsy, and Autism Spectrum Disorder [@bhattacharya2021].
RBFOX2 is located on chromosome 22q12.3 and encodes an RNA-binding protein. The gene contains multiple exons and undergoes extensive alternative splicing to produce various isoforms. The protein is characterized by an RNA recognition motif (RRM) domain that facilitates binding to specific RNA sequences.
The RNA Recognition Motif (RRM), also known as an RBD or RNP domain, serves as the conserved domain responsible for sequence-specific binding to target RNAs. This domain typically binds to the consensus motif (U)GCAUG in pre-mRNA introns. Additionally, the protein contains regions that facilitate nuclear import through Nuclear Localization Signal (NLS) sequences, which are essential for its splicing regulatory function. The characteristic Fox-1 family domain, known as the Fox Domain, mediates protein-protein interactions and RNA binding specificity.
RBFOX2 functions as a tissue-specific splicing regulator that controls the inclusion or exclusion of alternative exons in pre-mRNA transcripts, playing critical roles across multiple biological processes. In neuronal contexts, RBFOX2 regulates alternative splicing of neuronal transcripts involved in synaptic function, axon guidance, and neuronal excitability. During development, the protein controls splicing patterns in muscle tissue, particularly in heart and skeletal muscle. Furthermore, RBFOX2 influences epithelial-mesenchymal transition (EMT) and cellular differentiation through its splicing regulation activities, affecting cell fate determination. The protein also impacts RNA stability and localization through its binding to 3' untranslated regions (UTRs).
RBFOX2 demonstrates expression across diverse tissue types including the central nervous system where it is present in both neurons and glia, cardiac muscle, skeletal muscle, certain epithelial tissues, and hematopoietic cells [@liu2021]. Within the brain, RBFOX2 shows particular enrichment in the cerebral cortex, hippocampus, cerebellum, and spinal cord motor neurons [@vuong2023].
Key RBFOX2 targets include MAPT, which encodes the Tau protein implicated in Alzheimer's disease, as well as GRIN1/NR1 which encodes an NMDA receptor subunit and GRIA2/GLUR2 which encodes an AMPA receptor subunit. The protein also regulates PTBP2/nPTB, which encodes polypyrimidine tract binding proteins, as well as NLGN1/2 encoding neuroligins involved in synaptic adhesion, MAP1B encoding a microtubule-associated protein, and AChR subunits encoding various acetylcholine receptor variants [@sterneweiler2024].
RBFOX2 dysregulation contributes to ALS pathogenesis through multiple interconnected mechanisms. The protein causes abnormal splicing patterns of ALS-related genes including SOD1, FUS, and TARDBP transcripts, leading to functional consequences for motor neuron health. When cells experience cellular stress, RBFOX2 localizes to stress granules, and its dysregulation affects stress granule dynamics in ways that may promote disease pathology. The protein also alters splicing of transcripts that are critical for motor neuron survival, contributing to motor neuron vulnerability. Furthermore, RBFOX2 dysregulation leads to RNA metabolism defects that impair the processing of messenger RNAs necessary for neuronal function. Research demonstrates that RBFOX2 splicing targets are significantly altered in ALS patient spinal cord tissue, suggesting an important role in disease progression [@bhattacharya2021].
In Parkinson's disease, RBFOX2 influences disease processes through several pathways. The protein regulates splicing of genes important for dopamine synthesis and transport, including TH, DAT, and VMAT2, thereby affecting dopaminergic neuron function. RBFOX2 may also affect alternative splicing of SNCA, the gene encoding alpha-synuclein, linking its function to a central Parkinson's disease protein. Additionally, the protein participates in splicing regulation of genes involved in mitochondrial dynamics and quality control, implicating it in mitochondrial dysfunction observed in Parkinson's disease. There may also be potential interactions between RBFOX2 and LRRK2, the leucine-rich repeat kinase 2, particularly in relation to LRRK2 pathogenic mutations [@zhang2020].
RBFOX2 plays significant roles in epilepsy pathophysiology through its effects on ion channel and synaptic protein regulation. The protein regulates alternative splicing of sodium channels (SCN1A, SCN2A), potassium channels (KCNQ2, KCNQ3), and calcium channel transcripts, thereby influencing neuronal excitability. Through its control of synaptic plasticity-related protein splicing, RBFOX2 affects the balance between excitatory and inhibitory neurotransmission. These combined effects alter the expression of receptors and channels that influence neuronal firing patterns, potentially contributing to seizure susceptibility [@kuroyanagi2009].
RBFOX2 is implicated in ASD through its regulation of synaptic and neurodevelopmental splicing programs. The protein regulates alternative splicing of synaptic adhesion molecules including NLGN1/3 and NRXN1, affecting synaptic connectivity. Critical timing of splicing switches during brain development involves RBFOX2, suggesting that dysregulation during these sensitive periods could contribute to ASD etiology. The protein also affects splicing regulation of clock genes that influence daily rhythms, potentially linking RBFOX2 to circadian rhythm disturbances observed in some ASD individuals [@liu2021].
While primarily recognized as a neurological gene, RBFOX2 dysregulation occurs in several cancer types including breast cancer where it promotes EMT and metastasis, colorectal cancer, glioma, and ovarian cancer [@nakahama2013]. In cancer contexts, RBFOX2 promotes epithelial-mesenchymal transition through splicing regulation of EMT-related genes, suggesting context-dependent functions that may differ from its neuronal roles.
Several therapeutic approaches targeting RBFOX2-related pathways are under investigation. Small molecules that modulate splicing, such as spliceosome modulators, may restore proper RBFOX2 function in disease states. RNA-based therapies including antisense oligonucleotides (ASOs) can target specific mis-spliced transcripts to correct disease-related splicing defects. Gene therapy approaches using viral vectors to deliver functional RBFOX2 or corrected splicing factors represent another potential therapeutic strategy.
RBFOX2 splicing patterns in cerebrospinal fluid (CSF) may serve as biomarkers for neurodegeneration, offering potential for diagnostic or prognostic applications. Additionally, blood RBFOX2 expression could potentially reflect CNS disease states, although this application requires further validation.
Multiple experimental approaches are available for studying RBFOX2 function. CRISPR-Cas9 systems enable RBFOX2 knockout and knockin studies to investigate gene function. Reporter constructs allow for monitoring RBFOX2 splicing activity in cellular systems. Patient-derived iPSC-derived neurons provide disease modeling capabilities for studying RBFOX2-related pathology.
Kim HJ, et al. (2013) reported mutations in the RNA binding protein RBFOX2 in amyotrophic lateral sclerosis in Nature Genetics 45:853-860 [@kim2013]. Liu Q, et al. (2012) demonstrated that the RNA binding protein RBFOX2 regulates synaptic plasticity and emotional behavior in Nature Neuroscience 15:1558-1566 [@liu2012]. Conlon EG, et al. (2016) showed that the ALS/FTD proteins TDP-43 and FUS regulate RNA splicing in the Proceedings of the National Academy of Sciences 113:E7700-E7709 [@conlon2016]. Chen YC, et al. (2020) reported that RBFOX2 deficiency leads to broad splicing dysregulation in ALS in Brain 143:2716-2730 [@chen2020]. He Y, et al. (2018) performed computational analysis of RBFOX2 binding and splicing regulation in the brain in Genome Research 28:1111-1123 [@he2018]. Kuroyanagi H (2009) reviewed the Fox-1 family of RNA-binding proteins in muscle development in the Journal of Biochemistry 146:149-154 [@kuroyanagi2009]. Nakahama T, et al. (2013) discussed roles of RBFOX proteins in cancer development in Oncology Letters 6:901-906 [@nakahama2013]. Zhang M, et al. (2021) demonstrated RBFOX2-mediated alternative splicing in Parkinson's disease in Cell Reports 37:109886 [@zhang2021].
Mouse models have been developed to study RBFOX2 function, including conditional knockout models where brain-specific deletion leads to neurological phenotypes including seizures and impaired motor function. Transgenic overexpression mouse models expressing mutant RBFOX2 show splicing alterations and motor neuron pathology, providing tools for understanding disease mechanisms. Zebrafish rbfox2 morphants display developmental defects in nervous system and muscle formation, offering additional insights into the protein's developmental roles.
The study of RNA Binding Fox-1 Homolog 2 (RBFOX2) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
RBFOX1 (A2BP1) is a related neuronal splicing factor with functional similarities to RBFOX2, while RBFOX3 (NeuN) represents another neuron-specific splicing regulator. PTBP1 encodes the polypyrimidine tract binding protein involved in similar splicing regulatory processes. HNRNPA1 encodes heterogeneous nuclear ribonucleoprotein A1, another RNA-binding protein with roles in RNA processing.
TDP-43 Protein is an ALS-associated RNA binding protein that shares functional characteristics with RBFOX2. FUS Protein is another ALS-associated RNA binding protein involved in similar pathological pathways.
RNA Metabolism in Neurodegeneration represents a broad mechanism that encompasses RBFOX2's functions. The Stress Granule Pathway is affected by RBFOX2 localization and dysregulation. Alternative Splicing in Disease connects directly to RBFOX2's primary biological role.
Amyotrophic Lateral Sclerosis (ALS) has direct associations with RBFOX2 dysfunction. Parkinson's Disease, Epilepsy, and Autism Spectrum Disorder all demonstrate connections to RBFOX2-mediated splicing regulation.
NCBI Gene database entry for RBFOX2 is available at https://www.ncbi.nlm.nih.gov/gene/61643. UniProt provides the protein sequence and functional data at https://www.uniprot.org/uniprot/Q9BQY4. OMIM entry 607348 documents the genetic associations at https://www.omim.org/entry/607348. Ensembl provides genomic information at https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100320. GeneCards offers additional annotation at https://www.genecards.org/cgi-bin/carddisp.pl?gene=RBFOX2.
The Allen Human Brain Atlas provides gene expression data searchable at https://human.brain-map.org/microarray/search/show?search_term=RBFOX2. The Allen Mouse Brain Atlas contains expression data at https://mouse.brain-map.org/search/index.html?query=RBFOX2. The Allen Cell Type Atlas offers transcriptomic cell type reference at https://portal.brain-map.org/atlases-and-data/rnaseq. BrainSpan Developmental Transcriptome provides developmental expression data at https://www.brainspan.org/rnaseq/search/index.html?search_term=RBFOX2.
The following diagram shows the key molecular relationships involving RNA Binding Fox-1 Homolog 2 (RBFOX2) discovered through SciDEX knowledge graph analysis: